How many investments has Venture Capital Investment Management made?

Venture Capital Investment Management has 26 tracked investments, 4 of which have exited.

What stage does Venture Capital Investment Management invest at?

Venture Capital Investment Management invests at the Seed, Series A stages.

What sectors does Venture Capital Investment Management focus on?

Venture Capital Investment Management focuses on Biotech, Digital Health, Healthtech, Sector Agnostic.

Where is Venture Capital Investment Management located?

Venture Capital Investment Management is headquartered in San Francisco, US.

Who does Venture Capital Investment Management co-invest with?

Venture Capital Investment Management most often shares deals with Firebolt Ventures Management Company, Llc, Rethink Impact, Silver Lake Partners, among 17 tracked co-investors.

Venture Capital Investment Management

Venture capital

San Francisco · Seed–Series A · 7 people tracked

Also known as HAMBRECHT PARTNERS HOLDINGS, LLC

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Venture Capital Investment Management

332 people in our graph share verified history with the Venture Capital Investment Management team — schools, employers, funds. One of them is your warm intro.

Houman Haghighiunlockedknows Elizabeth Hambrecht · together at Techstars (overlapped)

×11knows the team · via Techstars

✨ Fox Verdict

Investment thesis

The firm invests in early-stage healthcare disruptors, drawing on Disruption Theory (per Clayton Christensen's The Innovator's Dilemma) which holds that new entrants succeed more often by targeting lower-cost, lower-performing or non-mainstream market tiers rather than competing head-on with incumbents. It views healthcare as ripe for disruption as decision power shifts from hospitals and doctors toward consumers and self-insured employers, creating opportunities to back young companies at lower valuations. The firm uses a proprietary big-data and computing system called MESE to screen hundreds of early-stage candidates daily and proactively source top targets, rather than relying only on inbound deal flow.

Invests inBiotech Digital Health HealthtechSector AgnosticGlobal San Francisco

Source: firm website, verified Sep 15, 2026.

Stage

Seed–Series A

San Francisco, US

Founded

1972

Private fund assets

$93.9M

VC funds

Tracked investments

Unicorns

IPOs

Acquisitions

Team · 7 people

from the firm's website

Bill Hambrecht· Partner

Partner at Hambrecht Ventures, founder of WR Hambrecht+Co, and co-founder of Hambrecht & Quist. He has overseen nearly 700 company investments including early-stage funding and IPO transactions for Apple, Amazon, Adobe, Genentech, Google, Intel, Nvidia, Pixar, and Salesforce. He serves on the boards of Buoy Health and PatientsLikeMe.

Elizabeth Hambrecht· Managing Partner

Managing Partner at Hambrecht Ventures who has collaborated with her father Bill Hambrecht for over a decade. She previously served as CEO of Salon Media, co-founded Asiacontent.com, and worked as an equities analyst at Goldman Sachs covering emerging markets. She sits on the boards of Tasso Inc., Proov, and Golden.

Gene Yates· Chief Financial Officer

Chief Financial Officer of WR Hambrecht + Co since 2014 with over 25 years of senior finance experience in financial services. Previously served as CFO at Wells Fargo Securities and held controller and regulatory roles at Charles Schwab. Holds a BS in Accounting & Finance from USC.

John Hullar· Advisory Role

Served as Managing Partner at WRH+Co from 2013 to 2018. Held executive positions including President and CEO at Wells Fargo Securities and Managing Director of the Western Region. Previously led institutional sales and brokerage operations at Morgan Stanley and H&Q. Holds a B.A. in Economics and Political Science from Yale University.

Lee Ting· Advisory Role

Retired Hewlett Packard executive with over 31 years of experience, most recently as Corporate Vice President managing operations across 120+ countries. Since 2001 has been a Partner at Hambrecht Ventures Funds 1 and 2 focusing on early-stage technology and bioscience investments in the US and China. Serves on multiple boards and holds a BS in Electrical Engineering from Oregon State University.

Thomas Thurston· Partner

Manages the technical team behind the firm's proprietary MESE big-data and computing platform used to identify and analyze disruptive companies.

Veronica Bryan· Partner, Operations and Human Resources

Has held HR and operations positions at WR Hambrecht + Co since 1999, supporting both Hambrecht Capital and Hambrecht Ventures as well as portfolio companies. Previously served as AVP at Bank of America.

What they invest in

from 8 of 26 portfolio companies

Biotech ×3Healthtech ×3AI & Machine Learning ×2Digital Health ×2Medical Devices ×2Advanced Manufacturing ×1AgTech ×1FoodTech ×1

HQs:United States×7

Investments · 26 tracked

founders shown can be your intro path

By year:2019 · 2 2014 · 13 dated

GoodRxNASDAQ: GDRX

GoodRx operates a digital platform that aggregates prescription pricing from pharmacies and healthcare industry sources, allowing consumers to compare medication costs and access discounted prices through negotiated pharmacy networks; the platform also connects consumers with telehealth services, prescription delivery, and direct affordability solutions from pharmaceutical manufacturers.

Douglas Hirsch(Director)Trevor Bezdek(Co-Chairman & Director)Wendy Barnes(Chief Executive Officer, President & Director)

Co-investorsConnetic Ventures Firebolt Ventures Management Company, Llc Francisco Partners Michael Ovitz Silver Lake Partners Wonder Ventures+1 more

AeroFarmsaerofarms.com in 𝕏

AeroFarms uses indoor vertical farming, artificial intelligence, and plant biology on a proprietary agriculture platform to grow fresh produce year-round with traceability and food safety.

AgTechAI & Machine LearningFoodTech

David Rosenberg(Founder)in

Co-investorsIngka Investments Middleland Capital ADM Capital AllianceBernstein Doha Venture Capital Grosvenor Food & AgTech +2 more

Calithera Biosciences inJul 2014Defunct

Calithera Biosciences was a clinical-stage biopharmaceutical company developing small-molecule oncology drugs targeting tumor metabolism, including the glutaminase inhibitor telaglenastat.

BiotechSouth San Francisco, US

Susan M. Molineaux(Executive Officer, Director)in William Waddill(Executive Officer)in

BoardJean M. George(Director)Deepa Pakianathan(Director)inRalph E. Christoffersen(Director)Jonathan Drachman(Director)

Co-investorsLongwood Fund The Column Group

Color Genomics in

BiotechBurlingame, US

Othman Laraki(Executive Officer, Director)in Elad Gil(Executive Officer, Director)in

BoardTaneja Hemant(Director)

Co-investorsGeneral Catalyst Khosla Ventures

Jounce Therapeuticsjouncetx.comAcquired

Jounce Therapeutics was a Cambridge, MA clinical-stage biopharmaceutical company developing cancer immunotherapies, including antibodies targeting ICOS and LILRB2/ILT4, guided by a biomarker-driven discovery platform.

BiotechCambridge, US

Kim C. Drapkin(Executive Officer)Anna L. Barry(Executive Officer)inRichard Murray(Executive Officer, Director)

Board Robert Tepper(Director)in Cary Pfeffer(Director)inRobert Kamen(Director)in

Co-investorsBoutique Venture Partners GENERAL INCEPTION Nextech Invest Sofinnova Ventures Third Rock Ventures

K Healthkhealth.ai

HealthtechNew York, US

Ran Shaul(Executive Officer)Allon Bloch(Executive Officer, Director)inAshok Balakrishnan(Executive Officer)Chen Yehudai(Executive Officer)inYaron Savoray(Executive Officer)Adam Singolda(Director)

Co-investorsComcast Ventures Lerer Hippeau Mangrove Capital Partners Notable Capital Partners Resolute Primary Venture Partners +9 more

Neurotrackneurotrack.com inMay 2019No public record

Neurotrack provides remote cognitive assessment tools for clinicians to detect early cognitive decline through eye-tracking technology, enabling earlier intervention for patients at risk of Alzheimer's and cognitive conditions.

AI & Machine LearningDigital HealthHealthtechMedical DevicesRedwood City, US

Elli Kaplan(Co-founder & CEO)inDr. Stuart Zola(Scientific Co-founder)Dr. Elizabeth Buffalo(Scientific Co-founder)Cecelia Manzanares(Co-founder)

BoardMichael Johns(Director)

Co-investorsRethink Impact Sozo Ventures

Tassotassoinc.com in 𝕏Dec 2019

Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.

Digital HealthHealthtechMedical DevicesSeattle, US

Ben Casavant(Co-Founder and Chief Executive Officer)in Erwin Berthier(Co-Founder and Chief Technology Officer)inAlan Levy(Director)

BoardElizabeth Hambrecht(Director)Paul Conley(Director)in

Co-investorsForesite Capital J2 Ventures OMX Ventures RA Capital Techstars Vertical Venture Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ACTIVEAmuseArcimotoBurt's BeesCardiometrixElevateFintech platform in ChinaMedidataMindstrongMothershipOmbreŌnRoSalesforceSurveySampling InternationalTangoTeamViewerToms of Maine

Exits · 4

1 IPOs · 3 acquisitions · showing 3

GoodRxNASDAQ: GDRXSurveySampling Internationalacq. by Research Now (merger, later rebranded as Dynata)Toms of Maineacq. by Colgate-Palmolive

Portfolio news

latest coverage across their companies

AeroFarms secures funding to build second vertical farm

AeroFarms · finance.yahoo.com · Aug 11, 2025

Frequently asked questions

How many investments has Venture Capital Investment Management made?: Venture Capital Investment Management has 26 tracked investments, 4 of which have exited.
What stage does Venture Capital Investment Management invest at?: Venture Capital Investment Management invests at the Seed, Series A stages.
What sectors does Venture Capital Investment Management focus on?: Venture Capital Investment Management focuses on Biotech, Digital Health, Healthtech, Sector Agnostic.
Where is Venture Capital Investment Management located?: Venture Capital Investment Management is headquartered in San Francisco, US.
Who does Venture Capital Investment Management co-invest with?: Venture Capital Investment Management most often shares deals with Firebolt Ventures Management Company, Llc, Rethink Impact, Silver Lake Partners, among 17 tracked co-investors.

Similar investors

8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$100K – $50M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

$5M – $100M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.